Newsletter | June 29, 2026

06.29.26 -- Rethinking COGs From Upstream To Downstream

SPONSOR

Make confident process decisions—from preclinical to scale up.

Catch our process development virtual summit on demand and hear from experts across upstream analytics, purification, and advanced therapeutics. Watch one session or twenty. Click to explore all sessions.

FOCUS ON UPSTREAM MANUFACTURING

Finding Ways To Reduce Process COGs Upstream And Downstream

In this segment from the Bioprocess Online Live event “Optimizing Process Development Through Upstream And Downstream Integration,” our panelists discuss where they see the greatest opportunities for teams to reduce COGs and advise teams to take a holistic approach to cost reduction.

Metabolic Pathways And The Immune System

Metabolic pathways define immune cell roles, from glycolysis fueling inflammation to fatty acid oxidation sustaining memory and tolerance. Discover how energy metabolism shapes immune responses.

A Sustainable Future: Phasing Out Animal Testing

Examine a practical roadmap for replacing animal tests with advanced molecular methods, as well as how regulatory updates and innovative technologies are shaping a sustainable future.

From R&D Tool To GMP Solution: Is Glycoengineering Ready For Your Plant?

In this assessment of the in vitro glycoengineering technology we determine if it is suitable for the development, manufacturing, and analysis of therapeutic proteins.

Leveraging Transposase Technologies To Optimize Cell Line Development

Enable a wide array of genomic manipulation with the more regulated and efficient genomic insertion that's made possible by transposase-based technologies.

Unlock The Potential Of Your HEK Cell Line Development

Cut HEK cell line development to four months with 30% higher titers. Gain insight into how you can deliver faster, scalable biologics manufacturing. Access the full summary now.

The Science Of Cell Line Development For Biologics

Selecting and engineering the right cell line is not simply a technical milestone; it is a strategic decision that shapes cost of goods, development timelines, and the overall probability of success.

Simpler, Faster, Cheaper Advanced Therapy Manufacturing

Observe how TFDF-based perfusion technology boosts lentiviral vector production by over 10-fold, slashes costs, and accelerates the commercialization of CAR-T and other advanced cell therapies.

UPSTREAM MANUFACTURING SOLUTIONS

Discover Our Collaborative Customer-Focused Approach - INFORS HT

Optimize Your Cell Line Strategy For Better Viral Vector Production - Cytiva

Why Use Pseudomonas Flourescens For Protein Expression? - Primrose Bio

SPONSOR

Join leading experts for an insightful discussion on The Risk And Reality Of 3D Printed Parts In Single-Use Workflows. The advantages of 3D printing in process development are clear: engineers can create custom equipment, up to and including bioreactors for scale-up and scale-down initiatives and mitigating process integration challenges. Register for free on Bioprocess Online Live.

Connect With Bioprocess Online: